iGlow.world and Partners Announce a Groundbreaking Initiative, Building on Two Decades of Genetic Advancements to Empower Nuclear Weapons Exposed People & Their Descendants
For Immediate Release
8/24/2023 – Two decades after the landmark achievement of sequencing the human genome, iGlow.world, a collaboration between stillGLOWING.org and LABRATS.International has proudly partnered with Sequencing.com to usher in a new era of genetic empowerment tailored for nuclear weapons exposed people and their descendants. This pioneering initiative aims to bridge historical healthcare gaps, ensuring ionizing radiation exposed communities totalling more than 1.2 Million individuals globally have the ability to leverage the benefits of improving health outcomes through whole genome sequencing.
The Significance for Nuclear Weapons Exposed:
This highly valued community, having been exposed to nuclear radiation during their lives, face unique health challenges that have long been inadequately addressed. The sacrifices of these communities make it imperative that they receive specialized care.
Sequencing.com’s partnership with iGLOW.world is not just about harnessing the power of genetics, but about recognizing and addressing the care owed to these human beings. Sequencing.com’s next-level genetic mapping allows access to more precise, personalized healthcare solutions to ensure that impacted families receive the care they truly deserve.
Dr. Brandon Colby, CEO of Sequencing.com, remarked, “The sequencing of the human genome was a monumental step for science and medicine. Now, in collaboration with iGlow.world, we’re ensuring that this achievement translates into tangible benefits for communities like the Nuclear Veterans. Their unique health challenges deserve the best of what genomics can offer.”
Alan and Kathy, the leaders of iGlow.world, added, “As descendants of Nuclear Veterans from the US and UK who advocate for radiation exposed communities, our collaboration with Sequencing.com is a testament to our shared vision of a future where genetic insights lead to better health outcomes for all. Nuclear Veterans have given so much, and it’s our duty to ensure they and their families receive the best care informed by the latest in genetic science.”
ACTIONABLE DATA FOR PERSONALIZED CARE: Genetic mapping will provide nuclear weapons exposed people and their descendants with actionable data, enabling their healthcare providers to offer treatments tailored to their unique needs.
ADVOCACY FOR INCLUSIVE HEALTHCARE: With concrete genetic evidence, iGlow.world and its partners will champion more inclusive healthcare options, ensuring that the benefits of genetic advancements reach those who need them most.
EMPOWERMENT AND REPRESENTATION: Beyond data, this initiative is about giving voice and representation to and their descendants, ensuring their concerns are at the forefront of genetic healthcare advancements.
A MODEL FOR FUTURE ENDEAVORS: iGlow.world’s initiative serves as a beacon for other medically marginalized populations, showcasing the potential of genetics to address specific health concerns when combined with community engagement and advocacy.
For many years the descendants of these impacted communities across the world have suffered. Sequencing.com’s cutting edge genetic mapping technology empowers iGLOW.world with the tools to build the on-ramp for a unique global volunteer database. This diversity will allow us to analyze the generational impact and use the newest scientific advances to aid in preventing future suffering. Moving forward, leveraging this partnership, we can build the first database of radiation affected communities with the aim of improving the standardization of care globally.
iGlow.world is an innovative international collaboration dedicated to harnessing the power of technology and community engagement to make a meaningful difference in the lives of under-represented populations. With a focus on genetic data and personalized healthcare solutions, iGlow.world is at the forefront of initiatives that empower individuals with actionable insights, fostering a future where everyone has equal access to the benefits of scientific advancements.
Sequencing.com is a global leader in genomic data analysis and interpretation. Since its inception, the company has been committed to making genomics accessible and actionable for everyone. With a vast array of tools, applications, and educational resources, Sequencing.com empowers individuals and organizations to derive meaningful insights from genomic data, driving the next wave of personalized healthcare and research breakthroughs.
UK Alan Owen mailto:email@example.com +44 203 286 3988
US Kathy Sinai firstname.lastname@example.org +1 925 200 3991
Timeliness in the Wake of the DIVERSE Trials Act:
In the USA, the introduction of the Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act (DIVERSE Trials Act) in the Senate on 08/10/2021 underscores the pressing need
for initiatives like ours. The act emphasizes the importance of diversity in clinical trials and the utilization of digital technologies for decentralized clinical trials. iGlow.world’s initiative aligns perfectly with this legislative direction, leveraging the power of genomics and digital health technologies to ensure that Nuclear Veterans, a historically underrepresented group, can now access and benefit from personalized healthcare solutions.